These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Systemic photochemotherapy decreases the expression of IFN-γ, IL-12p40 and IL-23p19 in psoriatic plaques. Ravić-Nikolić A; Radosavljević G; Jovanović I; Zdravković N; Mitrović S; Pavlović S; Arsenijević N Eur J Dermatol; 2011; 21(1):53-7. PubMed ID: 21227895 [TBL] [Abstract][Full Text] [Related]
3. Expression of p53 protein before and after PUVA treatment in psoriasis. Hannuksela-Svahn A; Pääkkö P; Autio P; Reunala T; Karvonen J; Vähäkangas K Acta Derm Venereol; 1999 May; 79(3):195-9. PubMed ID: 10384915 [TBL] [Abstract][Full Text] [Related]
4. Influence of systemic photochemotherapy on regulatory T cells and selected cytokine production in psoriatic patients: a pilot study. Rotsztejn H; Zalewska A; Trznadel-Budźko E; Lewkowicz P; Banasik M; Tchórzewski H; Głowacka E Med Sci Monit; 2005 Dec; 11(12):CR594-8. PubMed ID: 16319792 [TBL] [Abstract][Full Text] [Related]
5. Connexin 26 in psoriatic skin before and after two conventional therapeutic modalities: methotrexate and PUVA. Shaker O; Abdel-Halim M Eur J Dermatol; 2012; 22(2):218-24. PubMed ID: 22361809 [TBL] [Abstract][Full Text] [Related]
6. The dynamics of gene expression of interleukin-19 and interleukin-20 and their receptors in psoriasis. Otkjaer K; Kragballe K; Funding AT; Clausen JT; Noerby PL; Steiniche T; Iversen L Br J Dermatol; 2005 Nov; 153(5):911-8. PubMed ID: 16225599 [TBL] [Abstract][Full Text] [Related]
7. Photodynamic therapy in psoriasis: suppression of cytokine production in vitro and recording of fluorescence modification during treatment in vivo. Boehncke WH; König K; Kaufmann R; Scheffold W; Prümmer O; Sterry W Arch Dermatol Res; 1994; 286(6):300-3. PubMed ID: 7979545 [TBL] [Abstract][Full Text] [Related]
8. Changes of skin blood flow and color on lesional and control sites during PUVA therapy for psoriasis. Suh DH; Kwon TE; Kim SD; Park SB; Kwon OS; Eun HC; Youn JI J Am Acad Dermatol; 2001 Jun; 44(6):987-94. PubMed ID: 11369911 [TBL] [Abstract][Full Text] [Related]
9. Insulin-like growth factor-1 in psoriatic plaques treated with PUVA and methotrexate. El-Komy M; Amin I; Zidan A; Kadry D; Zeid OA; Shaker O J Eur Acad Dermatol Venereol; 2011 Nov; 25(11):1288-94. PubMed ID: 21241374 [TBL] [Abstract][Full Text] [Related]
10. Epidermal T lymphocytes and dendritic cells in chronic plaque psoriasis: the effects of PUVA treatment. Baker BS; Swain AF; Griffiths CE; Leonard JN; Fry L; Valdimarsson H Clin Exp Immunol; 1985 Sep; 61(3):526-34. PubMed ID: 3878241 [TBL] [Abstract][Full Text] [Related]
11. Antiangiogenic effect of methotrexate and PUVA on psoriasis. Shaker OG; Khairallah M; Rasheed HM; Abdel-Halim MR; Abuzeid OM; El Tawdi AM; El Hadidi HH; Ashmaui A Cell Biochem Biophys; 2013 Nov; 67(2):735-42. PubMed ID: 23504632 [TBL] [Abstract][Full Text] [Related]
12. Interleukin-6 in the epidermis of patients with psoriasis before and during PUVA treatment. Oxholm A; Oxholm P; Staberg B; Bendtzen K Acta Derm Venereol; 1989; 69(3):195-9. PubMed ID: 2566221 [TBL] [Abstract][Full Text] [Related]
13. Clinical improvement in chronic plaque-type psoriasis lesions after narrow-band UVB therapy is accompanied by a decrease in the expression of IFN-gamma inducers -- IL-12, IL-18 and IL-23. Piskin G; Tursen U; Sylva-Steenland RM; Bos JD; Teunissen MB Exp Dermatol; 2004 Dec; 13(12):764-72. PubMed ID: 15560760 [TBL] [Abstract][Full Text] [Related]
14. Cytokine release by peripheral blood mononuclear cells is affected by 8-methoxypsoralen plus UV-A. Neuner P; Charvat B; Knobler R; Kirnbauer R; Schwarz A; Luger TA; Schwarz T Photochem Photobiol; 1994 Feb; 59(2):182-8. PubMed ID: 8165238 [TBL] [Abstract][Full Text] [Related]
15. PUVA bath therapy strongly suppresses immunological and epidermal activation in psoriasis: a possible cellular basis for remittive therapy. Vallat VP; Gilleaudeau P; Battat L; Wolfe J; Nabeya R; Heftler N; Hodak E; Gottlieb AB; Krueger JG J Exp Med; 1994 Jul; 180(1):283-96. PubMed ID: 7516410 [TBL] [Abstract][Full Text] [Related]
16. The cytokine network in lesional and lesion-free psoriatic skin is characterized by a T-helper type 1 cell-mediated response. Uyemura K; Yamamura M; Fivenson DF; Modlin RL; Nickoloff BJ J Invest Dermatol; 1993 Nov; 101(5):701-5. PubMed ID: 7693825 [TBL] [Abstract][Full Text] [Related]
17. PUVA irradiation restores altered binding patterns of lectins in psoriatic epidermis. Danno K; Yoneda K; Horio T Arch Dermatol; 1986 Jul; 122(7):772-8. PubMed ID: 2425750 [TBL] [Abstract][Full Text] [Related]
18. Epidermal expression of interleukin-6 and tumour necrosis factor-alpha in normal and immunoinflammatory skin states in humans. Oxholm A APMIS Suppl; 1992; 24():1-32. PubMed ID: 1567657 [TBL] [Abstract][Full Text] [Related]
19. Evaluation of apoptosis regulatory proteins in response to PUVA therapy for psoriasis. El-Domyati M; Moftah NH; Nasif GA; Abdel-Wahab HM; Barakat MT; Abdel-Aziz RT Photodermatol Photoimmunol Photomed; 2013 Feb; 29(1):18-26. PubMed ID: 23281693 [TBL] [Abstract][Full Text] [Related]
20. Psoralen loaded liposomal nanocarriers for improved skin penetration and efficacy of topical PUVA in psoriasis. Doppalapudi S; Jain A; Chopra DK; Khan W Eur J Pharm Sci; 2017 Jan; 96():515-529. PubMed ID: 27777066 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]